Status:
COMPLETED
Changes in the Hypotalamic-pituitary Region of Patients With Metabolic Syndrome and Obesity
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Overweight and Obesity
Metabolic Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to identify new morphological and quantitative magnetic imaging parameters of pituitary gland and sellar region in overweight and obese patient at baseline and after 3 years, dividing ...
Detailed Description
This longitudinal prospective study in overweight and obese patients aims to identify and characterize new morphological and quantitative MRI parameters of pituitary gland and sellar region assessed b...
Eligibility Criteria
Inclusion
- BMI \> 25 Kg/m2
Exclusion
- Malignant neoplasia;
- Current use of psychotropic drugs;
- Chronic renal failure;
- Pituitary macroadenomas and craniopharyngiomas;
- Contraindications to MRI execution (p. e. pace-maker, metal foreign bodies like slivers, non MRI compatible vascular clips or prosthesis)
Key Trial Info
Start Date :
November 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT03458533
Start Date
November 1 2016
End Date
June 30 2020
Last Update
December 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Andrea M Isidori
Rome, Italy, 00161